CRISPR Therapeutics (CRSP) Insider Trading & Ownership $47.26 +0.29 (+0.62%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$12.51 M Get CRSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRSP Insider Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. CRISPR Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Samarth KulkarniCEOSell30,000$55.62$1,668,600.00 10/14/2024James R KasingerGeneral CounselSell1,089$46.28$50,398.92 10/14/2024Samarth KulkarniCEOSell4,293$46.28$198,680.04 6/21/2024Julianne BrunoCOOSell3,366$56.09$188,798.94 4/15/2024Samarth KulkarniCEOSell19,582$59.91$1,173,157.62 3/15/2024Raju PrasadCFOSell3,524$72.69$256,159.56 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/15/2024Samarth KulkarniCEOSell20,000$72.48$1,449,600.00 3/11/2024James R KasingerGeneral CounselSell2,801$78.26$219,206.26 3/11/2024Samarth KulkarniCEOSell9,802$78.26$767,104.52 2/20/2024James R KasingerGeneral CounselSell1,913$79.67$152,408.71 2/20/2024Samarth KulkarniCEOSell6,370$79.67$507,497.90 2/15/2024Samarth KulkarniCEOSell20,000$80.36$1,607,200.00 1/29/2024Samarth KulkarniCEOSell50,000$60.51$3,025,500.00 1/16/2024Samarth KulkarniCEOSell20,000$62.50$1,250,000.00 (Data available from 1/1/2013 forward) CRSP Insider Trading Activity - Frequently Asked Questions Who is on CRISPR Therapeutics's Insider Roster? The list of insiders at CRISPR Therapeutics includes James R Kasinger, Julianne Bruno, Raju Prasad, and Samarth Kulkarni. Learn more on insiders at CRSP. What percentage of CRISPR Therapeutics stock is owned by insiders? 4.10% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings. Which CRISPR Therapeutics insiders have been selling company stock? The following insiders have sold CRSP shares in the last 24 months: James R Kasinger ($422,013.89), Julianne Bruno ($188,798.94), Raju Prasad ($256,159.56), and Samarth Kulkarni ($20,514,590.08). How much insider selling is happening at CRISPR Therapeutics? Insiders have sold a total of 367,740 CRISPR Therapeutics shares in the last 24 months for a total of $21,381,562.47 sold. CRISPR Therapeutics Key ExecutivesDr. Rodger Novak M.D. (Age 55)Founder, Chairman & Pres Dr. Samarth Kulkarni (Age 43)CEO & Director Compensation: $1.18M2 recent tradesDr. Lawrence Otto Klein Ph.D. (Age 40)Chief Operating Officer Compensation: $675kMr. James R. Kasinger (Age 50)Gen. Counsel & Sec. Compensation: $648.93k1 recent tradesMr. Shaun FoyFounderDr. Emmanuelle Marie CharpentierCo-Founder & Scientific Advisory Board MemberDr. Craig C. Mello Ph.D.Scientific Founder & Advisory Board MemberDr. Chad Cowan Ph.D.Scientific FounderDr. Matthew Porteus M.D. (Age 56)Ph.D., Scientific Founder & Advisory Board Member Dr. Daniel G. Anderson Ph.D.Scientific Founder & Advisory Board Member More Insider Trading Tools from MarketBeat Related Companies Allogene Therapeutics Insider Trades Sangamo Therapeutics Insider Trades Fate Therapeutics Insider Trades Adverum Biotechnologies Insider Trades bluebird bio Insider Trades Precision BioSciences Insider Trades Moderna Insider Trades Neurocrine Biosciences Insider Trades Vaxcyte Insider Trades Bio-Techne Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CRSP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
